PortfoliosLab logoPortfoliosLab logo
JANX vs. VICI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

JANX vs. VICI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Janux Therapeutics, Inc. (JANX) and VICI Properties Inc. (VICI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JANX achieves a -1.52% return, which is significantly lower than VICI's -1.41% return.


JANX

1D
-1.38%
1M
-5.76%
YTD
-1.52%
6M
-20.57%
1Y
-46.56%
3Y*
-0.20%
5Y*
10Y*

VICI

1D
-0.94%
1M
-2.88%
YTD
-1.41%
6M
-0.45%
1Y
-8.78%
3Y*
0.70%
5Y*
2.26%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

JANX vs. VICI - Yearly Performance Comparison


2026 (YTD)20252024202320222021
JANX
Janux Therapeutics, Inc.
-1.52%-74.22%398.97%-18.53%-33.25%-21.55%
VICI
VICI Properties Inc.
-1.41%1.90%-3.07%3.58%13.01%-4.91%

Correlation

The correlation between JANX and VICI is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Jun 14, 2021

0.21

The correlation between JANX and VICI shifts across timeframes, from 0.04 (1 year) to 0.21 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

JANX:

$851.63M

VICI:

$29.15B

EPS

JANX:

-$1.84

VICI:

$2.92

PS Ratio

JANX:

39.07

VICI:

7.17

PB Ratio

JANX:

0.90

VICI:

1.03

Total Revenue (TTM)

JANX:

$21.61M

VICI:

$4.05B

Gross Profit (TTM)

JANX:

$8.44M

VICI:

$3.01B

EBITDA (TTM)

JANX:

-$134.03M

VICI:

$2.90B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JANX vs. VICI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JANX
JANX Risk / Return Rank: 1717
Overall Rank
JANX Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
JANX Sortino Ratio Rank: 2020
Sortino Ratio Rank
JANX Omega Ratio Rank: 1717
Omega Ratio Rank
JANX Calmar Ratio Rank: 1414
Calmar Ratio Rank
JANX Martin Ratio Rank: 1717
Martin Ratio Rank

VICI
VICI Risk / Return Rank: 2020
Overall Rank
VICI Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
VICI Sortino Ratio Rank: 1616
Sortino Ratio Rank
VICI Omega Ratio Rank: 1717
Omega Ratio Rank
VICI Calmar Ratio Rank: 2424
Calmar Ratio Rank
VICI Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JANX vs. VICI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Janux Therapeutics, Inc. (JANX) and VICI Properties Inc. (VICI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


JANXVICIDifference

Sharpe ratio

Return per unit of total volatility

-0.63

-0.54

-0.09

Sortino ratio

Return per unit of downside risk

-0.43

-0.65

+0.22

Omega ratio

Gain probability vs. loss probability

0.92

0.92

0.00

Calmar ratio

Return relative to maximum drawdown

-0.72

-0.49

-0.23

Martin ratio

Return relative to average drawdown

-1.10

-0.85

-0.25

JANX vs. VICI - Sharpe Ratio Comparison

The current JANX Sharpe Ratio is -0.63, which is comparable to the VICI Sharpe Ratio of -0.54. The chart below compares the historical Sharpe Ratios of JANX and VICI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


JANXVICIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.63

-0.54

-0.09

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.11

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.09

0.34

-0.43

Drawdowns

JANX vs. VICI - Drawdown Comparison

The maximum JANX drawdown since its inception was -83.14%, which is greater than VICI's maximum drawdown of -60.21%. Use the drawdown chart below to compare losses from any high point for JANX and VICI.


Loading charts...

Drawdown Indicators


JANXVICIDifference

Max Drawdown

Largest peak-to-trough decline

-83.14%

-60.21%

-22.93%

Max Drawdown (1Y)

Largest decline over 1 year

-64.94%

-17.88%

-47.06%

Max Drawdown (3Y)

Largest decline over 3 years

-81.78%

-17.88%

-63.90%

Max Drawdown (5Y)

Largest decline over 5 years

-18.61%

Current Drawdown

Current decline from peak

-79.67%

-15.81%

-63.86%

Average Drawdown

Average peak-to-trough decline

-52.01%

-8.17%

-43.84%

Ulcer Index

Depth and duration of drawdowns from previous peaks

42.42%

10.35%

+32.07%

Volatility

JANX vs. VICI - Volatility Comparison

Janux Therapeutics, Inc. (JANX) has a higher volatility of 9.11% compared to VICI Properties Inc. (VICI) at 4.24%. This indicates that JANX's price experiences larger fluctuations and is considered to be riskier than VICI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JANXVICIDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.11%

4.24%

+4.87%

Volatility (6M)

Calculated over the trailing 6-month period

82.02%

12.29%

+69.73%

Volatility (1Y)

Calculated over the trailing 1-year period

74.22%

16.44%

+57.78%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

131.36%

20.97%

+110.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

131.36%

29.29%

+102.07%

Dividends

JANX vs. VICI - Dividend Comparison

JANX has not paid dividends to shareholders, while VICI's dividend yield for the trailing twelve months is around 6.53%.


PositionTTM20252024202320222021202020192018
JANX
Janux Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VICI
VICI Properties Inc.
6.53%6.28%5.80%5.05%4.63%4.58%4.92%4.58%5.31%

Financials

JANX vs. VICI - Financials Comparison

This section allows you to compare key financial metrics between Janux Therapeutics, Inc. and VICI Properties Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B20222023202420252026
3.73M
1.02B
(JANX) Total Revenue
(VICI) Total Revenue
Values in USD except per share items

Frequently Asked Questions


JANX and VICI have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

JANX has higher volatility (9.11%) compared to VICI (4.24%). In terms of maximum drawdown, JANX dropped -83.14% vs VICI's -60.21%.

VICI currently has the higher Sharpe Ratio (-0.54 vs -0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JANX and VICI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer